Abstract

As in the rest of the neocortex, there are three major categories of excitatory neurotransmitters and receptors in the prefrontal cortex: glutamate, monoamines, and acetylcholine. The essential monoamines are norepinephrine, dopamine, and serotonin. All excitatory neurotransmitters activate cognitive prefrontal functions. Norepinephrine and dopamine commonly produce inverted-U dose-related effects, with detrimental effects on cognition at high doses. Some neuropeptides have general excitatory functions by modulating norepinephrine and dopamine. γ-Aminobutyric acid (GABA) is the most prevalent inhibitory neurotransmitter. In the attention deficit/hyperactivity disorder of childhood, there is a deficit in tyrosine hydroxylase expression leading to a dopamine imbalance and secondary GABA deficit in orbitofrontal cortex. Schizophrenia is accompanied by cortical and striatal connectivity imbalance in several neurotransmitter and receptor systems, notably dopamine and GABA. Depression affects prefrontal serotonin. Parkinson’s disease is characterized by a dopamine deficit in the basal ganglia, secondarily affecting prefrontal cortex. Dementia commonly affects cholinergic and monoaminergic systems.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.